Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Moodys
Federal Trade Commission
Fuji
Teva
Johnson and Johnson
AstraZeneca
Healthtrust

Generated: February 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NICOTINE

« Back to Dashboard

Clinical Trials for Nicotine

Trial ID Title Status Sponsor Phase Summary
NCT00000284 Role of Metabolites in Nicotine Dependence (1) - 1 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms.
NCT00000284 Role of Metabolites in Nicotine Dependence (1) - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms.
NCT00000288 Role of Metabolites in Nicotine Dependence (2) - 5 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 The purpose of this study is to determine the effects of varying doses of cotinine on cigarette self-administration.
NCT00000288 Role of Metabolites in Nicotine Dependence (2) - 5 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to determine the effects of varying doses of cotinine on cigarette self-administration.
NCT00000289 Role of Metabolites in Nicotine Dependence (3) - 6 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 The purpose of this study is to determine the effects of various doses of ondansetron transdermal nicotine replacement on tobacco withdrawal symptoms.
NCT00000289 Role of Metabolites in Nicotine Dependence (3) - 6 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to determine the effects of various doses of ondansetron transdermal nicotine replacement on tobacco withdrawal symptoms.
NCT00000295 Progesterone Treatment in Female Smokers - 12 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 The purpose of this study is to investigate progesterone effects in female smokers
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Nicotine

Condition Name

Condition Name for Nicotine
Intervention Trials
Smoking Cessation 161
Nicotine Dependence 109
Smoking 101
Tobacco Use Disorder 83
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nicotine
Intervention Trials
Tobacco Use Disorder 245
Schizophrenia 49
Alcoholism 24
Disease 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nicotine

Trials by Country

Trials by Country for Nicotine
Location Trials
United States 786
Canada 45
Sweden 23
France 17
Germany 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nicotine
Location Trials
California 75
Minnesota 57
Pennsylvania 54
Connecticut 53
Texas 45
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nicotine

Clinical Trial Phase

Clinical Trial Phase for Nicotine
Clinical Trial Phase Trials
Phase 4 138
Phase 3 76
Phase 2/Phase 3 25
[disabled in preview] 292
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nicotine
Clinical Trial Phase Trials
Completed 423
Recruiting 124
Not yet recruiting 65
[disabled in preview] 118
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nicotine

Sponsor Name

Sponsor Name for Nicotine
Sponsor Trials
National Institute on Drug Abuse (NIDA) 160
National Cancer Institute (NCI) 52
Yale University 45
[disabled in preview] 111
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nicotine
Sponsor Trials
Other 780
NIH 297
Industry 173
[disabled in preview] 39
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Healthtrust
Teva
Queensland Health
Accenture
Cantor Fitzgerald
Deloitte
Chubb
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.